Physician profile
Ryan Eric Gursky
NPI 1366581068
$20,924.36
in general payments reported to CMS, 2019-2025
14 companies · $73.05 in 2025
The $73.05 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,060 · 2020: $1,626 · 2021: $16K · 2022: $214 · 2023: $140 · 2024: $1,404 · 2025: $73.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1,404 · Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,404.00 |
| Food and Beverage | $212.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $20,349.90 | 2019-2024 | Onvoy |
| Takeda Pharmaceuticals U.S.A., INC. | $134.80 | 2022-2023 | Entyvio, Gattex |
| Intercept Pharmaceuticals, INC. | $122.44 | 2022-2023 | Ocaliva |
| Janssen Biotech, INC. | $55.85 | 2022 | |
| Biocomposites INC | $50.59 | 2020 | |
| Depuy Synthes Sales INC. | $42.50 | 2025 | Na, Lcp |
| Innovation Technologies INC | $37.08 | 2021 | |
| Baxter Healthcare | $30.55 | 2025 | Tisseel |
| Davol INC. | $27.60 | 2022 | |
| Pacira Therapeutics, INC. | $20.82 | 2019 | |
| Zyla Life Sciences, INC. | $15.07 | 2019 | |
| Ethicon US, LLC | $12.90 | 2022 | |
| Horizon Therapeutics Plc | $12.31 | 2019 | |
| Bioventus LLC | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gursky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.